VHL, Jade-1 and protein stability in renal cancer
VHL, Jade-1 and protein stability in renal cancer
批准号:
6919315
负责人:
HERBERT TOD COHEN
金额:
$32.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-01 至 2008-04-30
关键词:
DNA binding proteinapoptosisathymic mousechemical stabilitychromatinclinical researchgene expressiongenetic regulationhuman subjecthuman tissueimmunoprecipitationkidney neoplasmsligasepoint mutationposttranslational modificationsprotein bindingprotein degradationprotein localizationprotein protein interactionprotein structure functiontranscription factortumor suppressor proteinsubiquitin
中文摘要
超出所提供的空间。肾癌是一种对药物治疗具有高度抵抗力的毁灭性恶性肿瘤。VHL肿瘤抑制基因在大多数成人肾癌中发生突变。然而,VHL肿瘤抑制的机制尚不清楚。我们的实验室使用定向方法来寻找在肾癌中重要的VHL相互作用蛋白,已经将Jade-1(上皮细胞凋亡和分化基因)鉴定为特别强的VHL相互作用因子。Jade-1是一种新的肾脏富集的PEST和植物同源结构域蛋白,是一个新的蛋白质家族的成员。Jade-1是蛋白酶体降解途径的短寿命靶标,并且具有强烈的促凋亡作用,因为它降低细胞粘附并直接促进染色质致密化。VHL阻断Jade-1诱导的细胞凋亡并稳定Jade-1蛋白,这是一种新的VHL功能。此外,我们现在已经表明,Jade-1稳定是VHL突变依赖性的,非肾癌引起的VHL错义突变能够稳定Jade-1像野生型VHL。因此,Jade-1稳定是第一个显示与肾癌风险实质相关的VHL活性,表明它与疾病有关。Jade-1通过VHL的稳定是高度特异性的,因为它还没有被观察到与已知的或潜在的VHL合作伙伴。Jade-1以VHL依赖性方式是低氧诱导的,并且在条件性VHL缺失小鼠中显示改变的翻译后修饰的证据。因此,我们已经建立了令人信服的证据VHL-玉-1关系的真实性以及玉-1的令人信服的生物学意义。我们提出以下目标:1. VHL-Jade-1蛋白相互作用及Jade-1在肾癌组织中的表达VHL依赖的Jade-1稳定和修饰3. Jade-1在细胞凋亡和细胞应激中的作用及VHL 4的调节作用Jade-1作为转录因子和染色质致密化,以及VHL性能位点的调节==
英文摘要
EXCEED THE SPACE PROVIDED. Renal cancer is a devastating malignancy that is highly resistant to medical therapy. The VHL tumor suppressor is mutated in most adult renal cancers. Yet, the mechanism of VHL tumor suppression is not known. Using a directed approach to find VHL-interacting proteins important in renal cancer, our laboratory has identified Jade-1 (gene for Apoptosis and Differentiation in Epithelia) as a particularly strong VHL interactor. Jade-l, a novel, kidney-enriched, PEST and plant homeodomain protein, is a member of a new protein family. Jade-1 is a short-lived target of the proteasome degradation pathway and is strongly pro-apoptotic, as it decreases cellular adhesion and directly promotes chromatin compaction. VHL blocks Jade-l-induced apoptosis and stabilizes Jade-1 protein, which is a new VHL function. Moreover, we have now shown that Jade-1 stabilization is VHL mutation-dependent, with non-renal cancer-causing VHL missense mutations able to stabilize Jade-1 like wild-type VHL. Jade-1 stabilization is therefore the first VHL activity to show substantial correlation with renal cancer risk, suggesting it has a disease relationship. Stabilization of Jade-1 by VHL is highly specific, as it has not been observed with known or potential VHL partners. Jade-1 is hypoxia-inducible in a VHL dependent manner and shows evidence of altered post-translational modification in conditional VHL null mice. Thus, we have established convincing evidence of the VHL-Jade-1 relationship's authenticity as well as Jade-1 's compelling biological significance. We propose the following Aims: 1. The VHL-Jade-1 protein-protein interaction, and Jade-1 expression in renal cancer tissue 2. VHL-dependent Jade-1 stabilization and modification 3. Jade-1 in apoptosis and cell stress, and modulation by VHL 4. Jade-1 as a transcription factor and in chromatin compaction, and modulation by VHL PERFORMANCE SITE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Jade-1 in cystic renal disease
-
批准号:6861859
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
Jade-1 in cystic renal disease
-
批准号:7049325
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
Jade-1 in cystic renal disease
-
批准号:6768201
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
Jade-1 in cystic renal disease
-
批准号:7379930
-
项目类别:
-
资助金额:$29.62万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
Jade-1 in cystic renal disease
-
批准号:7234711
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:6686928
-
项目类别:
-
资助金额:$32.2万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VEGF TRANSCRIPTIONAL REGULATION BY TUMOR SUPPRESSOR VHL
-
批准号:2733434
-
项目类别:
-
资助金额:$31.63万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:7227198
-
项目类别:
-
资助金额:$30.53万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8585027
-
项目类别:
-
资助金额:$31.06万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8196861
-
项目类别:
-
资助金额:$32.02万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VEGF TRANSCRIPTIONAL REGULATION BY TUMOR SUPPRESSOR VHL
-
批准号:6173732
-
项目类别:
-
资助金额:$29.27万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:7999259
-
项目类别:
-
资助金额:$32.02万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8578133
-
项目类别:
-
资助金额:$6.48万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8787179
-
项目类别:
-
资助金额:$6.69万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VEGF TRANSCRIPTIONAL REGULATION BY TUMOR SUPPRESSOR VHL
-
批准号:6376964
-
项目类别:
-
资助金额:$33.55万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8527928
-
项目类别:
-
资助金额:$2.23万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8387038
-
项目类别:
-
资助金额:$30.1万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:7084646
-
项目类别:
-
资助金额:$31.44万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:6777002
-
项目类别:
-
资助金额:$32.2万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:7782104
-
项目类别:
-
资助金额:$33.01万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: